Pre-radiotherapy PSA progression is a negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors.

Daniel TausskyJulie PiotteKevin C ZornMarc ZanatyVimal KrishnanCarole LambertJean-Paul BaharyMarie-Claude BeaucheminMaroie BarkatiCynthia MénardGuila Delouya

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2017)

PSA progression experienced during 5‑ARI treatment before radiotherapy is predictive of worse biochemical outcome. Such details should be considered when counseling men prior to radiation therapy.

Keyphrases

prostate cancer
radiation therapy
prognostic factors
locally advanced
early stage
radiation induced
radical prostatectomy
rectal cancer
squamous cell carcinoma
hiv testing
human immunodeficiency virus